AmerisourceBergen Co. (NYSE:ABC) Shares Sold by Sawyer & Company Inc

Sawyer & Company Inc cut its stake in shares of AmerisourceBergen Co. (NYSE:ABC – Get Rating) by 2.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 15,434 shares of the company’s stock after selling 410 shares during the quarter. Sawyer & Company Inc’s holdings in AmerisourceBergen were worth $2,558,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. United Bank boosted its position in shares of AmerisourceBergen by 16.6% in the 1st quarter. United Bank now owns 3,632 shares of the company’s stock worth $562,000 after buying an additional 518 shares in the last quarter. Raymond James Trust N.A. boosted its position in shares of AmerisourceBergen by 29.9% in the 1st quarter. Raymond James Trust N.A. now owns 5,193 shares of the company’s stock worth $803,000 after buying an additional 1,194 shares in the last quarter. Synovus Financial Corp boosted its position in shares of AmerisourceBergen by 123.4% in the 1st quarter. Synovus Financial Corp now owns 6,301 shares of the company’s stock worth $975,000 after buying an additional 3,480 shares in the last quarter. Vontobel Holding Ltd. boosted its position in shares of AmerisourceBergen by 22.5% in the 1st quarter. Vontobel Holding Ltd. now owns 2,767 shares of the company’s stock worth $430,000 after buying an additional 508 shares in the last quarter. Finally, Blair William & Co. IL boosted its position in shares of AmerisourceBergen by 12.4% in the 1st quarter. Blair William & Co. IL now owns 8,124 shares of the company’s stock worth $1,257,000 after buying an additional 899 shares in the last quarter. 84.79% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently commented on ABC. UBS Group boosted their price objective on shares of AmerisourceBergen from $184.00 to $190.00 and gave the stock a “buy” rating in a research report on Tuesday, January 31st. TheStreet lowered shares of AmerisourceBergen from a “b-” rating to a “c” rating in a report on Monday, March 6th. StockNews.com assumed coverage on shares of AmerisourceBergen in a research note on Thursday. They set a “strong-buy” rating for the company. Evercore ISI reaffirmed an “outperform” rating and set a $185.00 price objective on shares of AmerisourceBergen in a research note on Tuesday, January 31st. Finally, Credit Suisse Group upped their price objective on shares of AmerisourceBergen from $175.00 to $182.00 and gave the company an “outperform” rating in a research note on Tuesday, November 22nd. Two investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $180.08.

AmerisourceBergen Stock Down 0.0 %

ABC opened at $152.02 on Friday. The firm has a 50 day moving average price of $158.84 and a 200 day moving average price of $156.06. The company has a market cap of $30.75 billion, a PE ratio of 18.45, a price-to-earnings-growth ratio of 1.50 and a beta of 0.54. AmerisourceBergen Co. has a 1 year low of $135.14 and a 1 year high of $174.63. The company has a debt-to-equity ratio of 63.30, a quick ratio of 0.53 and a current ratio of 0.91.

AmerisourceBergen (NYSE:ABC – Get Rating) last posted its earnings results on Wednesday, February 1st. The company reported $2.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.62 by $0.09. The firm had revenue of $62.85 billion during the quarter, compared to the consensus estimate of $62.77 billion. AmerisourceBergen had a net margin of 0.72% and a return on equity of 597.57%. The company’s revenue was up 5.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.58 EPS. Sell-side analysts expect that AmerisourceBergen Co. will post 11.61 earnings per share for the current year.

AmerisourceBergen Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 27th. Shareholders of record on Friday, February 10th were given a $0.485 dividend. This represents a $1.94 annualized dividend and a yield of 1.28%. The ex-dividend date was Thursday, February 9th. AmerisourceBergen’s dividend payout ratio (DPR) is 23.54%.

Insider Buying and Selling at AmerisourceBergen

In other AmerisourceBergen news, EVP Gina Clark sold 1,924 shares of the stock in a transaction that occurred on Wednesday, March 1st. The shares were sold at an average price of $156.22, for a total value of $300,567.28. Following the completion of the sale, the executive vice president now owns 26,733 shares of the company’s stock, valued at $4,176,229.26. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other AmerisourceBergen news, EVP Gina Clark sold 1,924 shares of the stock in a transaction that occurred on Wednesday, March 1st. The shares were sold at an average price of $156.22, for a total value of $300,567.28. Following the completion of the sale, the executive vice president now owns 26,733 shares of the company’s stock, valued at $4,176,229.26. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Lazarus Krikorian sold 2,218 shares of the stock in a transaction that occurred on Wednesday, December 21st. The shares were sold at an average price of $169.24, for a total transaction of $375,374.32. Following the completion of the sale, the chief accounting officer now directly owns 20,007 shares of the company’s stock, valued at approximately $3,385,984.68. The disclosure for this sale can be found here. Insiders sold 30,851 shares of company stock valued at $4,865,455 over the last 90 days. 20.10% of the stock is owned by corporate insiders.

AmerisourceBergen Profile

(Get Rating)

AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies.